Lifeward

Lifeward Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Lifeward (LFWD) as of Nov 22, 2026 is 84.49 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 75.04 % — a change of 12.60% (higher).

Cash Conversion

84.49 %

YoY

12.60%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Lifeward is 2025 84.49 % . Cash Conversion Rate (OCF/Net Income) of Lifeward was 2024 75.04 % . It decreases by 12.60% higher compared to the previous year.

The Lifeward Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2018
68.16 USD
Jan 1, 2019
95.27 USD
Jan 1, 2020
97.02 USD
Jan 1, 2021
90.05 USD
Jan 1, 2022
91.43 USD
Jan 1, 2023
93.38 USD
Jan 1, 2024
75.04 USD
Jan 1, 2025
84.49 USD
The Lifeward Cash Conversion history
YEARCash ConversionYoY
84.49 %+12.60%
75.04 %-19.64%
93.38 %+2.13%
91.43 %+1.53%
90.05 %-7.18%
97.02 %+1.84%
95.27 %+39.77%
68.16 %-25.12%
91.02 %+7.44%
84.72 %-14.49%
99.08 %+54.55%
64.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

Cash Conversion Rate (OCF/Net Income) of Lifeward is 84.49 % in 2025.

Cash Conversion Rate (OCF/Net Income) of Lifeward changed from 75.04 % to 84.49 %, representing a 12.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Lifeward since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Lifeward with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Lifeward

All Key Metrics — Lifeward